We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

90 hedge funds and large institutions have $88.6M invested in 9 Meters Biopharma in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 11

109% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 11

70% more capital invested

Capital invested by funds: $52.2M → $88.6M (+$36.4M)

58% more funds holding

Funds holding: 57 → 90 (+33)

17% less call options, than puts

Call options by funds: $2.98M | Put options by funds: $3.6M

Holders
90
Holders Change
+33
Holders Change %
+57.89%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
23
Reduced
11
Closed
11
Calls
$2.98M
Puts
$3.6M
Net Calls
-$623K
Net Calls Change
-$210K

Top Buyers

Rank Fund Capital Flow
1
TLP
Tri Locum Partners
New York
+$8.07M
2
CH
CVI Holdings
Delaware
+$3.28M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.76M
4
Millennium Management
Millennium Management
New York
+$2.61M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.54M

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$2.68M
2
ACM
Altium Capital Management
New York
-$1.09M
3
SC
Saltoro Capital
Texas
-$937K
4
WVP
Worth Venture Partners
New Jersey
-$678K
5
MS
Maven Securities
Jersey
-$667K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$30.1M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$17.1M +$2.54M +82,500 +13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$10.5M +$2.76M +89,826 +25%
TLP
4
Tri Locum Partners
New York
$7.77M +$8.07M +262,676 +378%
BlackRock
5
BlackRock
New York
$4.4M +$1.12M +36,300 +24%
CH
6
CVI Holdings
Delaware
$2.5M +$3.28M +106,723 New
Millennium Management
7
Millennium Management
New York
$2.19M +$2.61M +84,984 +987%
MWNA
8
Marshall Wace North America
New York
$1.73M +$2.27M +73,998 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.53M +$775K +25,233 +63%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$1.38M +$1.7M +55,430 +1,559%
Citigroup
11
Citigroup
New York
$936K +$1.23M +40,000 New
HF
12
HRT Financial
New York
$670K +$881K +28,670 New
SM
13
Sabby Management
Florida
$661K +$867K +28,226 New
Two Sigma Investments
14
Two Sigma Investments
New York
$631K +$829K +26,965 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$622K +$816K +26,570 New
CIP
16
Chartwell Investment Partners
Pennsylvania
$552K +$725K +23,580 New
PCM
17
Perkins Capital Management
Minnesota
$410K +$76.8K +2,500 +17%
Northern Trust
18
Northern Trust
Illinois
$375K +$166K +5,402 +51%
ECM
19
ExodusPoint Capital Management
New York
$347K +$384K +12,504 +542%
Citadel Advisors
20
Citadel Advisors
Florida
$259K +$341K +11,088 New
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$253K +$250K +8,128 +303%
VFA
22
Valeo Financial Advisors
Indiana
$232K +$238K +7,745 +358%
Truist Financial
23
Truist Financial
North Carolina
$204K +$268K +8,730 New
Group One Trading
24
Group One Trading
Illinois
$178K +$234K +7,611 New
Squarepoint
25
Squarepoint
New York
$170K +$224K +7,286 New
1
2 3 4

NMTR Hedge Fund Activity: Q1 2021 in Review

90 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q1 2021, worth a combined $88.6M — up 70% from $52.2M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NMTR positions and 11 closed out — a net gain of 33 holders — while 23 added to existing stakes and 11 trimmed.

The largest buyer was Tri Locum Partners, adding an estimated $8.07M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.68M sold.

  • 90 institutional investors held 9 Meters Biopharma (NMTR) as of Q1 2021, up from 57 in Q4 2020.
  • Funds reported $88.6M of 9 Meters Biopharma stock for Q1 2021, up 70% quarter-over-quarter.
  • 44 funds opened new 9 Meters Biopharma positions in Q1 2021 and 11 closed out, a net change of +33 holders.
  • The largest 9 Meters Biopharma buyer in Q1 2021 was Tri Locum Partners, an estimated $8.07M added.
  • The largest 9 Meters Biopharma seller in Q1 2021 was AIGH Capital Management, an estimated $2.68M sold.

Based on aggregated 13F filings for Q1 2021.